Sentinel Lymph Node Biopsy in Prostate Cancer: An Overview of Diagnostic Performance, Oncological Outcomes, Safety, and Feasibility

Sentinel node biopsy (SNB) for prostate cancer (PCa) represents an innovative technique aimed at improving nodal staging accuracy. The routinary adoption of this procedure in patients undergoing radical prostatectomy (RP) might be crucial to identify candidates who could effectively benefit from ext...

Full description

Bibliographic Details
Published in:Diagnostics
Main Authors: Giulio Rossin, Federico Zorzi, Pedro De Pablos-Rodríguez, Arianna Biasatti, Josè Marenco, Luca Ongaro, Alessandro Perotti, Gabriele Tulone, Fabio Traunero, Andrea Piasentin, Alvaro Gomez-Ferrer, Alessandro Zucchi, Carlo Trombetta, Alchiede Simonato, José Rubio-Briones, Riccardo Bartoletti, Miguel Ramírez-Backhaus, Francesco Claps
Format: Article
Language:English
Published: MDPI AG 2023-07-01
Subjects:
prostate cancer
extended pelvic lymph node dissection
nodal staging
sentinel lymph node biopsy
sentinel lymph node
indocyanine green
Online Access:https://www.mdpi.com/2075-4418/13/15/2543
Description
Summary:Sentinel node biopsy (SNB) for prostate cancer (PCa) represents an innovative technique aimed at improving nodal staging accuracy. The routinary adoption of this procedure in patients undergoing radical prostatectomy (RP) might be crucial to identify candidates who could effectively benefit from extensive pelvic lymph nodal dissection (ePLND). Despite some promising results, SNB for PCa is still considered experimental due to the lack of solid evidence and procedural standardization. In this regard, our narrative review aimed to analyze the most recent literature in this field, providing an overview of both the diagnostic accuracy measures and the oncological outcomes of SNB.
ISSN:2075-4418

Similar Items